HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katharina Seystahl Selected Research

Katharina Seystahl Research Topics

Disease

14Glioblastoma (Glioblastoma Multiforme)
02/2022 - 05/2012
12Neoplasms (Cancer)
02/2022 - 01/2012
8Glioma (Gliomas)
06/2021 - 01/2013
3Meningioma (Meningiomas)
01/2019 - 03/2016
2Venous Thromboembolism
01/2022 - 11/2021
2Necrosis
04/2021 - 01/2016
2Hemangioblastoma
01/2014 - 01/2012
1Brain Neoplasms (Brain Tumor)
01/2022
1Edema (Dropsy)
03/2016
1Brain Edema (Cerebral Edema)
03/2016
1Hypoxia (Hypoxemia)
02/2015
1Cysts
02/2014
1Lymphoma (Lymphomas)
09/2012
1Leukemia
09/2012

Drug/Important Bio-Agent (IBA)

7Bevacizumab (Avastin)FDA Link
03/2020 - 01/2012
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021 - 01/2012
4Biomarkers (Surrogate Marker)IBA
11/2016 - 02/2015
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2017 - 02/2015
3Biological ProductsIBA
01/2017 - 01/2016
2Irinotecan (Camptosar)FDA LinkGeneric
03/2020 - 01/2013
2Temozolomide (Temodar)FDA LinkGeneric
06/2016 - 01/2013
2cediranib (AZD2171)IBA
01/2016 - 05/2012
1Oxygen (Dioxygen)IBA
02/2022
1Carbon DioxideIBA
02/2022
1vinyltriethoxysilane (VTES)IBA
01/2022
1AnticoagulantsIBA
01/2022
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2022
1C-Reactive ProteinIBA
11/2021
1Hemoglobins (Hemoglobin)IBA
11/2021
1EndoglinIBA
06/2021
1LigandsIBA
06/2021
1Alkylating AgentsIBA
03/2020
1thiamine triphosphorate (TTP)IBA
01/2020
1Plasminogen InactivatorsIBA
01/2017
1Protein Isoforms (Isoforms)IBA
01/2017
1Antisense OligonucleotidesIBA
01/2017
1Messenger RNA (mRNA)IBA
01/2017
1LY-2157299IBA
12/2016
1Radioisotopes (Radionuclides)IBA
11/2016
1Somatostatin Receptors (Somatostatin Receptor)IBA
11/2016
1Edotreotide (SMT 487)IBA
11/2016
1Antineoplastic Agents (Antineoplastics)IBA
03/2016
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2016
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2016
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2016
1Tyrosine Kinase InhibitorsIBA
01/2016
1Neutralizing AntibodiesIBA
01/2016
1Lomustine (CCNU)FDA Link
10/2014
1Dasatinib (BMS 354825)FDA Link
09/2012
1CytokinesIBA
09/2012
1afliberceptIBA
05/2012
1Angiogenesis InhibitorsIBA
05/2012
1enzastaurinIBA
05/2012

Therapy/Procedure

4Radiotherapy
04/2021 - 01/2013
4Drug Therapy (Chemotherapy)
03/2020 - 01/2013
4Therapeutics
11/2016 - 01/2014
2Aftercare (After-Treatment)
01/2019 - 01/2012
1Chemoradiotherapy
01/2022
1Terminal Care (Care, Terminal)
05/2020
1Immunotherapy
03/2016
1Ventriculostomy
02/2014